Search

Displaying results 5641 - 5650 of 8171 in total

Drug
TPX-4589
go.drugbank.com/drugs/DB18604
Investigational
TPX-4589 is an antibody-drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAE.
Drug
XL019
go.drugbank.com/drugs/DB05243
Investigational
An IND for XL019 was filed by Exelixis in May 2007.
Drug
Telapristone acetate
go.drugbank.com/drugs/DB05253
Investigational
Telapristone acetate, an orally-available, selective progesterone receptor modulator, is in development to alleviate symptoms associated with both uterine fibroids and endometriosis.
Drug
IRX-2
go.drugbank.com/drugs/DB05643
Investigational
It is being investigated to promote or enhance an anti-cancer immune response.
Drug
H3B-8800
go.drugbank.com/drugs/DB14017
Investigational
H3B-8800 is a novel spliceosome inhibitor developed by H3 Biomedicine . It offers the benefit of preferentially killing spliceosome-mutant cancer cells whereas other splicesome inhibitors, such as the pladienolide analogue E7107, show no...
Drug
SJG-136
go.drugbank.com/drugs/DB11965
Investigational
SJG-136 has been used in trials studying the treatment of Recurrent Fallopian Tube Cancer, Secondary Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes, Recurrent Ovarian Epithelial Cancer, and
Categories: P-glycoprotein substrates
Drug
Filapixant
go.drugbank.com/drugs/DB21467
Experimental
Filapixant has a monoisotopic molecular weight of 521.17 Da.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 Substrates
Drug
Teplinovivint
go.drugbank.com/drugs/DB21475
Experimental
Teplinovivint has a monoisotopic molecular weight of 442.21 Da.
Drug
Ipivivint
go.drugbank.com/drugs/DB21479
Experimental
Ipivivint has a monoisotopic molecular weight of 464.19 Da.
Drug
Vornorexant
go.drugbank.com/drugs/DB21483
Experimental
Vornorexant has a monoisotopic molecular weight of 447.18 Da.